Cargando…
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
OBJECTIVES: We aimed to compare the spectrum and severity of COVID-19 and vaccine breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and inflammatory diseases (SAIDs), and healthy controls (HCs). METHODS: This is a cross-sectional study with data from the COVAD study,...
Ejemplares similares
-
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
por: Sen, Parikshit, et al.
Publicado: (2021) -
COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies
por: Gil‐Vila, Albert, et al.
Publicado: (2022) -
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey
por: Naveen, R., et al.
Publicado: (2023) -
COVAD survey 2 long-term outcomes: unmet need and protocol
por: Fazal, Zoha Zahid, et al.
Publicado: (2022) -
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
por: Naveen, R, et al.
Publicado: (2022)